| Literature DB >> 31697766 |
Qi Yao1, Ge Zhou2, Meilin Xu3, Jianguo Dai1, Ziwei Qian1, Zijing Cai1, Luyao Zhang1, Yong Tan2, Rongkui Hu2.
Abstract
Environmental exposure to metals is ubiquitous, but its relation to androgen hormone levels is not well understood, especially in children and adolescents. This study aimed to explore the relationship between blood metal concentrations (lead, cadmium, total mercury, selenium, and manganese) and serum total testosterone (TT) levels in 6-19-year-old children and adolescents in the National Health and Nutrition Examination Survey (NHANES) 2011-2012. Weighted multivariable linear regression models using NHANES sampling weights were employed to evaluate the association between log-transformed serum TT and each metal categories in male and female children (age 6-11years) and adolescents (age 12-19 years). We established that blood cadmium and manganese levels were associated with significantly higher serum TT levels in the female adolescents. Additionally, the blood selenium levels in male adolescents were related to significantly higher serum TT. No significant associations between blood lead or total mercury levels and TT were observed in children or adolescents of either sex. These findings suggest that environmental exposure to certain metals could affect serum TT levels in adolescents, which might have important implications for the health of adolescents. Further research is required to confirm and extend our present findings.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31697766 PMCID: PMC6837506 DOI: 10.1371/journal.pone.0224892
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characteristics of the 6–19-year-old children and adolescent participants in NHANES 2011–2012.
| Parameter | Male | Male | Female | Female |
|---|---|---|---|---|
| n | 431 | 493 | 426 | 470 |
| Age (years) | 9 (7–10) | 15(14–17) | 9 (7–10) | 15(13–17) |
| Serum total testosterone (ng/dL) | 3.16 (1.80–5.68) | 354.67(208.08–496.58) | 4.86 (2.69–10.29) | 23.95 (16.72–31.55) |
| Serum cotinine (ng/mL) | 0.035 (0.011–0.242) | 0.038 (0.011–0.431) | 0.039 (0.011–0.181) | 0.028 (0.011–0.210) |
| Ratio family income to poverty | 1.26(0.74–2.70) | 1.57 (0.86–3.40) | 1.30 (0.70–2.78) | 1.40 (0.69–2.96) |
| Obesity | ||||
| Normal/underweight | 263 (61.02%) | 309 (62.68%) | 266 (62.44%) | 297 (63.19%) |
| Overweight | 66 (15.31%) | 77 (15.62%) | 68 (15.96%) | 76 (16.17%) |
| Obese | 102 (23.67%) | 107 (21.70%) | 92 (21.60%) | 97 (20.64%) |
| Race/ethnicity | ||||
| Non-Hispanic White | 113 (26.22%) | 119 (24.14%) | 98(23.01%) | 105 (22.34%) |
| Non-Hispanic black | 116 (26.91%) | 154 (31.24%) | 128(30.05%) | 141 (30.00%) |
| Hispanic | 145 (33.64%) | 138 (27.99%) | 129(30.28%) | 144 (30.64%) |
| Other | 57 (13.23%) | 82 (16.63%) | 71(16.67%) | 80 (17.02%) |
| Session time of venipuncture | ||||
| Morning | 177 (41.07%) | 243 (49.29%) | 207 (48.59%) | 237 (50.43%) |
| Afternoon | 157 (36.43%) | 170 (34.48%) | 149 (34.98%) | 156 (33.19%) |
| Evening | 97 (22.51%) | 80 (16.23%) | 70 (16.43%) | 77 (16.38%) |
| Six-month period when the examination was performed | ||||
| 1 November through 30 April | 216 (50.12%) | 237 (48.29%) | 221 (51.88%) | 216 (45.96%) |
| 1 May through 31 October | 215 (49.88%) | 256 (51.93%) | 205 (48.12%) | 254 (54.04%) |
Data are summarized as median (interquartile range) for continuous variables or as number with proportion for categorical variables.
aChildren and adolescents were classified as normal/underweight, overweight, or obese according to their age and sex, as defined by NHANES (http:/wwwn.cdc.gov/Nchs/Nhanes/2011-2012/BMX_G.htm)
The distribution of metal concentrations in the blood of the 6–19-year-old children and adolescent participants in NHANES 2011–2012.
| Parameter | Male | Male | ||||||
| n | 431 | 493 | ||||||
| N(%)<LOD | Geometric | median | interquartile | N(%)<LOD | Geometric | median | interquartile | |
| Blood lead (μg/dL) | 7 (1.6%) | 0.76 | 0.72 | 0.52–1.02 | 11 (2.2%) | 0.68 | 0.66 | 0.47–0.96 |
| Blood cadmium (μg/L) | 311 (72.2%) | 0.13 | 0.11 | 0.11–0.16 | 237 (48.1%) | 0.17 | 0.16 | 0.11–0.23 |
| Blood mercury, total (μg/L) | 69 (16.0%) | 0.35 | 0.34 | 0.20–0.59 | 48 (9.7%) | 0.47 | 0.43 | 0.23–0.79 |
| Blood selenium (μg/L) | 0 (0.0%) | 174 | 175 | 163–188 | 0 (0.0%) | 187 | 187 | 174–202 |
| Blood manganese (μg/L) | 0 (0.0%) | 9.79 | 9.72 | 7.86–11.84 | 0 (0.0%) | 9.43 | 9.33 | 7.62–11.54 |
| Parameter | Female | Female | ||||||
| n | 426 | 470 | ||||||
| N(%)<LOD | Geometric | median | interquartile | N(%)<LOD | Geometric | median | interquartile | |
| Blood lead (μg/L) | 6 (1.4%) | 0.68 | 0.65 | 0.48–0.93 | 27 (5.8%) | 0.47 | 0.47 | 0.35–0.63 |
| Blood cadmium (μg/L) | 277 (65.0%) | 0.14 | 0.11 | 0.11–0.18 | 194 (41.3%) | 0.19 | 0.18 | 0.11–0.27 |
| Blood mercury, total (μg/L) | 61 (14.3%) | 0.39 | 0.36 | 0.22–0.66 | 40 (8.5%) | 0.50 | 0.49 | 0.26–0.83 |
| Blood selenium (μg/L) | 0 (0.0%) | 177 | 177 | 165–189 | 0 (0.0%) | 184 | 183 | 169–200 |
| Blood manganese (μg/L) | 0 (0.0%) | 10.55 | 10.52 | 8.72–12.90 | 0 (0.0%) | 10.75 | 10.84 | 8.64–13.26 |
Abbreviations: LOD, limit of detection
Percent differences (95% CI) in the serum TT by quartiles of blood lead exposure, NHANES, 2011–2012using weighted regression models.
| Blood lead(μg/dL) | Model 1 | Model2 |
|---|---|---|
| Male children(N = 431) | ||
| ≤0.52(n = 110) | Reference | Reference |
| 0.52–0.72(n = 111) | 4.1 (-18.47, 32.9) | 11.75(-13.06,43.65) |
| 0.72–1.02 (n = 105) | -6.13(-27.64, 21.77) | -4.63(-26.97, 24.55) |
| >1.02 (n = 105) | -12.83 (-33.68, 14.58) | -13.09 (-34.45,15.22) |
| Adjusted | 0.36 | 0.42 |
| Male adolescents(N = 493) | ||
| ≤0.47(n = 129) | Reference | Reference |
| 0.47–0.66 (n = 120) | -3.36 (-20.98,18.2) | -4.35 (-21.22,16.14) |
| 0.66–0.96 (n = 121) | 14.99 (-7.77,43.37) | 8.15 (-12.91,34.3) |
| >0.96 (n = 123) | 15.62 (-7.07,43.86) | 6.32 (-14.62,32.4) |
| Adjusted | 0.18 | 0.58 |
| Female children(N = 426) | ||
| ≤0.48(n = 109) | Reference | Reference |
| 0.48–0.65 (n = 106) | 14.34 (-3.75,35.81) | 14.9 (-3.54,36.86) |
| 0.65–0.93 (n = 106) | -5.00 (-21.05,14.32) | -0.96 (-17.80,19.34) |
| >0.93 (n = 105) | -5.73 (-23.13,15.61) | -2.40 (-21.00,20.57) |
| Adjusted | 0.36 | 0.63 |
| Female adolescents(N = 470) | ||
| ≤0.35 (n = 122) | Reference | Reference |
| 0.35–0.47 (n = 118) | -8.55 (-18.52,2.63) | -7.83 (-18.22,3.88) |
| 0.47–0.63 (n = 113) | -1.95 (-13.04,10.56) | -1.07 (-12.67,12.06) |
| >0.63 (n = 117) | 13.12 (0.06,27.88) | 14.85 (0.83,30.81) |
| Adjusted | 0.14 | 0.08 |
aAdjusted for age (continuous), BMI (normal/underweight, overweight, and obese) and race-ethnicity (Non-Hispanic White, Non-Hispanic black, Hispanic, and other).
b Adjusted for variables in model 1 plus serum cotinine (log-transformed, continuous), time of venipuncture (morning, afternoon, and evening), season of collection (1 November through 30 April, 1 May through 31 October), ratio family income to poverty (continuous).
c Adjusted p-trend:p-values adjusted for multiple testing.
Percent differences (95% CI) in serum TT betweenthree blood cadmium exposure levels, NHANES, 2011–2012using weighted regression models.
| Blood cadmium(μg/L) | Model 1 | Model2 |
|---|---|---|
| Male children(N = 431) | ||
| ≤0.11 (n = 311) | Reference | Reference |
| 0.11–0.20 (n = 73) | 6.87 (-16.33,36.51) | 17.65 (-8.02,50.47) |
| >0.20 (n = 47) | -14.39 (-39.09,20.3) | -8.04 (-34.62,29.35) |
| Adjusted | 0.86 | 0.83 |
| Male adolescents(N = 493) | ||
| ≤0.11 (n = 237) | Reference | Reference |
| 0.11–0.23 (n = 206) | 11.31 (-5.45,31.05) | 3.56 (-11.68,21.43) |
| >0.23 (n = 50) | 37.97 (4.45,82.26) | 21.68 (-11.70,67.68) |
| Adjusted | 0.04 | 0.62 |
| Female children(N = 426) | ||
| ≤0.11 (n = 227) | Reference | Reference |
| 0.11–0.20 (n = 91) | 16.19 (-1.16,36.59) | 18.24 (0.6,38.98) |
| >0.20 (n = 58) | -7.95 (-25.67,13.99) | -8.64 (-26.22,13.13) |
| Adjusted | 0.86 | 0.83 |
| Female adolescent(N = 470) | ||
| ≤0.11 (n = 194) | Reference | Reference |
| 0.11–0.25 (n = 200) | 13.24 (3.41,24) | 14.28 (4.31,25.19) |
| >0.25 (n = 76) | 23.15 (6.43,42.5) | 30.79 (9.7,55.94) |
| Adjusted | 0.0038 | 0.0015 |
a Adjusted for age (continuous), BMI (normal/underweight, overweight, and obese) and race-ethnicity (Non-Hispanic White, Non-Hispanic black, Hispanic and other).
b Adjusted for variables in model 1 plus serum cotinine (log-transformed, continuous), time of venipuncture (morning, afternoon, and evening), season of collection (1 November through 30 April, 1 May through 31 October), ratio family income to poverty.
c Adjusted p-trend:p-values adjusted for multiple testing.
Percent differences (95% CI) in serum TT by quartiles of blood mercury exposure, NHANES, 2011–2012using weighted regression models.
| Blood mercury(μg/L) | Model 1 | Model2 |
|---|---|---|
| Male children(N = 431) | ||
| ≤0.20 (n = 112) | Reference | Reference |
| 0.20–0.34 (n = 105) | 2.45 (-20.36,31.79) | 5.49 (-17.59,35.03) |
| 0.34–0.59 (n = 111) | 15.02 (-10.17,47.28) | 10.29 (-13.62,40.82) |
| >0.59 (n = 103) | 4.92 (-21.02,39.40) | 0.67 (-24.36,33.99) |
| Adjusted | 0.46 | 0.75 |
| Male adolescents(N = 493) | ||
| ≤0.23 (n = 125) | Reference | Reference |
| 0.23–0.43 (n = 123) | 18.47 (-3.05,44.76) | 13.75 (-6.45,38.32) |
| 0.43–0.79 (n = 123) | -10.63 (-28.14,11.14) | -8.68 (-26.14,12.91) |
| >0.79 (n = 122) | 21.77 (-2.77,52.5) | 19.28 (-4.21,48.55) |
| Adjusted | 0.46 | 0.70 |
| Female children(N = 426) | ||
| ≤0.22(n = 114) | Reference | Reference |
| 0.22–0.36 (n = 103) | 6.76 (-10.22,26.94) | 8.62 (-9.17,29.89) |
| 0.36–0.66 (n = 106) | 0.89 (-15.07,19.83) | 0.7 (-15.56,20.09) |
| >0.66 (n = 103) | 29.78 (7.96,56.00) | 29.15 (6.9,56.02) |
| Adjusted | 0.10 | 0.14 |
| Female adolescent(N = 470) | ||
| ≤0.26 (n = 120) | Reference | Reference |
| 0.26–0.49 (n = 118) | -4.72 (-14.67,6.39) | -2.75 (-13.25,9.03) |
| 0.49–0.83 (n = 116) | -2.45 (-13.49,10.00) | 0.05 (-11.56,13.17) |
| >0.83 (n = 116) | -8.28 (-19.6,4.64) | -5.84 (-17.78,7.83) |
| Adjusted | 0.46 | 0.70 |
a Adjusted for age (continuous), BMI(normal/underweight, overweight, and obese)and race-ethnicity(Non-Hispanic
White, Non-Hispanic black, Hispanic and other).
b Adjusted for variables in model 1 plus serum cotinine (log-transformed, continuous), time of venipuncture (morning, afternoon and evening), season of collection(1 November through 30 April, 1 May through 31 October), ratio family income to poverty (continuous).
c Adjusted p-trend:p-values adjusted for multiple testing.
Percent differences (95% CI) in serum TT by quartiles of blood selenium exposure, NHANES, 2011–2012using weighted regression models.
| Blood selenium(μg/L) | Model 1 | Model2 |
|---|---|---|
| Male children(N = 431) | ||
| ≤163 (n = 108) | Reference | Reference |
| 163–175 (n = 109) | -4.76 (-27.11,24.45) | -2.05 (-24.7,27.41) |
| 175–188 (n = 107) | -16.69 (-36.08,8.58) | -13.07 (-32.96,12.71) |
| >188 (n = 107) | -11.75 (-32.55,15.46) | -8.28 (-29.53,19.37) |
| Adjusted | 0.32 | 0.37 |
| Male adolescents(N = 493) | ||
| ≤174 (n = 126) | Reference | Reference |
| 174–187 (n = 121) | -17.49 (-34.47,3.91) | -18.3 (-34.67,2.16) |
| 187–202 (n = 123) | 2.33 (-18.44,28.39) | -4.98 (-23.91,18.67) |
| >202 (n = 123) | 43.27 (14.2,79.73) | 33.38 (6.99,66.29) |
| Adjusted | 0.0002 | 0.0027 |
| Female children(N = 426) | ||
| ≤165 (n = 107) | Reference | Reference |
| 165–177 (n = 106) | -16.76 (-30.82,0.18) | -17.64 (-31.6,-0.83) |
| 177–189 (n = 107) | -17.62 (-31.59,-0.80) | -21.52 (-35.01,-5.22) |
| >189 (n = 106) | -8.78 (-23.63,8.96) | -11.93 (-26.47,5.49) |
| Adjusted | 0.36 | 0.23 |
| Female adolescents(N = 470) | ||
| ≤169 (n = 118) | Reference | Reference |
| 169–183 (n = 117) | 4.68 (-7.33,18.25) | 4.55 (-7.51,18.19) |
| 183–200 (n = 118) | -6.45 (-16.98,5.41) | -7.79 (-18.3,4.08) |
| >200 (n = 117) | -7.93 (-18.29,3.75) | -8.23 (-18.56,3.42) |
| Adjusted | 0.13 | 0.10 |
a Adjusted for age (continuous), BMI (normal/underweight, overweight, and obese) and race-ethnicity (Non-Hispanic White, Non-Hispanic black, Hispanic, and other).
b Adjusted for variables in model 1 plus serum cotinine (log-transformed, continuous), time of venipuncture (morning, afternoon, and evening), season of collection (1 November through 30 April, 1 May through 31 October), ratio family income to poverty (continuous).
c Adjusted p-trend:p-values adjusted for multiple testing.
Percent differences (95% CI) in serum TT by quartiles of blood manganese exposure, NHANES, 2011–2012using weighted regression models.
| Blood Manganese(μg/L) | Model 1 | Model2 |
|---|---|---|
| Male children(N = 431) | ||
| ≤7.86 (n = 108) | Reference | Reference |
| 7.86–9.72 (n = 108) | 18.17 (-9.85,54.91) | 16.09 (-10.90,51.24) |
| 9.72–11.84 (n = 108) | 47.31 (13.23,91.66) | 48.55 (14.80,92.22) |
| >11.84 (n = 107) | 12.24 (-14.41,47.20) | 10.72 (-15.09,44.38) |
| Adjusted | 0.40 | 0.46 |
| Male adolescents(N = 493) | ||
| ≤7.62 (n = 124) | Reference | Reference |
| 7.62–9.33 (n = 124) | 38.64 (11.7,72.06) | 31.51 (6.78,61.96) |
| 9.33–11.54 (n = 123) | 25.2 (0.38,56.16) | 15.49 (-6.81,43.13) |
| >11.54 (n = 122) | 18.39 (-5.89,48.94) | 11.88 (-10.38,39.68) |
| Adjusted | 0.40 | 0.60 |
| Female children(N = 426) | ||
| ≤8.72 (n = 107) | Reference | Reference |
| 8.72–10.52 (n = 107) | -19.44 (-33.33,-2.65) | -21.3 (-34.91,-4.85) |
| 10.52–12.90 (n = 107) | -4.94 (-21.88,15.68) | -6.5 (-23.13,13.72) |
| >12.90 (n = 105) | -1.51 (-19.36,20.29) | -3.71 (-21.25,17.72) |
| Adjusted | 0.49 | 0.60 |
| Female adolescents(N = 470) | ||
| ≤8.64 (n = 119) | Reference | Reference |
| 8.64–10.84 (n = 116) | 23.04 (8.64,39.36) | 22.53 (7.98,39.04) |
| 10.84–13.26 (n = 118) | 34.59 (19.41,51.71) | 36.26 (20.72,53.81) |
| >13.26 (n = 117) | 24.96 (10.47,41.36) | 24.81 (10.31,41.23) |
| Adjusted | 0.001 | 0.0008 |
a Adjusted for age (continuous), BMI (normal/underweight, overweight, and obese) and race-ethnicity (Non-Hispanic White, Non-Hispanic black, Hispanic, and other).
b Adjusted for variables in model 1 plus serum cotinine (log-transformed, continuous), time of venipuncture (morning, afternoon, and evening), season of collection (1 November through 30 April, 1 May through 31 October), ratio family income to poverty (continuous).
c Adjusted p-trend:p-values adjusted for multiple testing.